Investing
First Look Analyst Calls Briefing for Monday, October 31, 2022
Published:
Last Updated:
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110
> Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160
Downgrades:
> ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman
> Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60
> Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James
> Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James
Others:
> Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13
> Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
